RecruitingNot ApplicableNCT03071536

Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation

Furosemide Stress Test as a Marker of Postoperative Kidney Allograft Function

Sponsor

King Chulalongkorn Memorial Hospital

Enrollment

180 participants

Start Date

Nov 25, 2016

Study Type

INTERVENTIONAL

Conditions

Kidney function Kidney Transplant; Complications Delayed Graft Function

Summary

Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Furosemide Injection for people with delayed graft function, kidney transplant; complications, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.